Similarly, among the AMPs tested against different clinical isolates of P. aeruginosa from CF patients, the ability of the IDR-1018 peptide to prevent biofilm formation has been reported, despite its weak activity against planktonic bacterial forms [31]. This evidence concerns the gene ADSL and cystic fibrosis.